Encouraging the Alabama Medicaid Agency to evaluate the overall costs of GLP-1 medications and report its findings
Pending Committee Action in House of Origin
Email me when HR 166 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track HR 166. By continuing you agree to the Terms and Privacy Policy.
Summary
The resolution asks the Alabama Medicaid Agency to evaluate the overall cost of providing GLP‑1 medications for weight management, consider potential savings from new federal drug‑pricing models, and discuss findings with providers. It would affect roughly 110,000 Medicaid adults and children who might qualify for these drugs and aims to guide future coverage decisions. The agency must deliver a report to the Legislature before the 2027 session.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about HR 166
3 free questions a day, no accountHistory
- Read for the first time and referred to the House Committee on Rules
- Pending Committee Action in House of Origin (Rules)
Sponsors
- Oliver · sponsor
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when HR 166 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track HR 166 freeOr ask your AI assistant about HR 166 directly:
Add to Claude, ChatGPT or Cursor